Vinva Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
236,846
+18,943
+9% +$1.52M 0.18% 126
2025
Q4
$20.9M Buy
217,903
+93,143
+75% +$9.13M 0.26% 98
2025
Q3
$12.1M Buy
124,760
+56,645
+83% +$5.87M 0.24% 109
2025
Q2
$7.26M Buy
68,115
+13,444
+25% +$1.36M 0.19% 134
2025
Q1
$5.43M Buy
54,671
+7,182
+15% +$723K 0.22% 123
2024
Q4
$4.26M Sell
47,489
-4,586
-9% -$404K 0.16% 142
2024
Q3
$4.34M Sell
52,075
-6,469
-11% -$510K 0.18% 128
2024
Q2
$4.51M Buy
58,544
+2,694
+5% +$197K 0.23% 111
2024
Q1
$3.83M Buy
55,850
+5,235
+10% +$337K 0.21% 124
2023
Q4
$2.85M Buy
50,615
+8,767
+21% +$468K 0.19% 132
2023
Q3
$2.23M Sell
41,848
-739
-2% -$38.8K 0.21% 116
2023
Q2
$2.27M Sell
42,587
-5,907
-12% -$309K 0.2% 127
2023
Q1
$2.41M Buy
+48,494
New +$2.29M 0.2% 131

Other funds holding BSX